BIOPHARMIA AS
Operating
Selskapets formål er å drive bioteknologisk næringsutvikling,
rådgivning forbundet hermed, eiendomsutvikling, handel samt hva hermed
står i forbindelse, herunder delta i andre selskaper, nasjonalt og
internasjonalt.
Links
Organization
- CEO
- RA
Roald Audun Flo1943
- Chairman of the board
- RA
Roald Audun Flo1943
- Years since formation
- 16 years
- since Feb 2, 2009
- Type
- Limited company
- VAT registered
- No
- Number of employees
- 0
Ownership
- Number of shares and share classes
- 224,444
- 1 share class
- Total number of shareholders
- 2
- persons
Financials
- Annual total result 2024
- -114,918
- NOK
- Total equity 2024
- 8,145,514
- NOK
Last update: Sep 9, 2025
Management
Management / administration
| Name | Role | Shares |
|---|---|---|
RA 1943 | Managing Director/CEO | 99.5 % directly |
Board
| Name | Role | Shares |
|---|---|---|
RA 1943 | Chairman | 99.5 % directly |
Others
| Name | Role | Shares |
|---|---|---|
| Accountant | - |
Top 10 individual shareholders
| Name | Role | Shares |
|---|---|---|
RA 1943 | Managing Director/CEO, Chairman | 99.5 % directly |
Last update: Apr 13, 2023
Ownership
Company shareholders
| Name | Share class | Total number of shares | Share |
|---|---|---|---|
RA 1943 | Ordinary shares | 223,333 | 99.5 % |
GC | Ordinary shares | 1,111 | 0.5 % |
Last update: Jun 2, 2025
Financials
in NOK
Summary
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Annual Total Result | -114,918 | -80,857 | -100,489 | -132,766 |
Total assets | 10,563,807 | 10,575,242 | 10,567,737 | 10,556,736 |
Total liabilities | 2,418,293 | 2,314,810 | 2,226,447 | 2,114,957 |
Total equity | 8,145,514 | 8,260,432 | 8,341,290 | 8,441,779 |
P&L
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total operating income | 0 | 0 | 0 | 0 |
Total operating costs | 114,919 | 80,858 | 100,489 | 132,766 |
Operating result | -114,919 | -80,858 | -100,489 | -132,766 |
Financial income/costs | 1 | 1 | 0 | 0 |
Profit before tax | -114,918 | -80,857 | -100,489 | -132,766 |
Total tax & extraordinary income/cost | 0 | 0 | 0 | 0 |
Annual Total Result | -114,918 | -80,857 | -100,489 | -132,766 |
Balance overview
| Year | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total fixed assets | 10,550,605 | 10,550,605 | 10,550,605 | 10,550,605 |
Total current assets | 13,202 | 24,637 | 17,132 | 6,132 |
Total assets | 10,563,807 | 10,575,242 | 10,567,737 | 10,556,736 |
Short term debt | 0 | 3,966 | 45,942 | 42,281 |
Long term debt | 2,418,293 | 2,310,843 | 2,180,505 | 2,072,677 |
Total liabilities | 2,418,293 | 2,314,810 | 2,226,447 | 2,114,957 |
Contributed capital | 10,283,302 | 10,283,302 | 10,283,302 | 10,283,302 |
Retained earnings | -2,137,788 | -2,022,870 | -1,942,012 | -1,841,523 |
Total equity | 8,145,514 | 8,260,432 | 8,341,290 | 8,441,779 |
Total equity and liabilities | 10,563,807 | 10,575,242 | 10,567,737 | 10,556,736 |
Classification
21st company classification
BETA
Small company
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises